Dragon Life Science Holdings Group, Inc. (NOHO)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | -19.03 Thousand | -1428.00 | - | -207.5 Thousand |
| Net Income | - | - | -264.19 Thousand | -44.25 Thousand | -140.42 Thousand | -272.26 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 245.16 Thousand | 44.25 Thousand | - | 64.76 Thousand |
| Other non-cash items | - | - | -1190.00 | -1428.00 | 140.42 Thousand | -1435.00 |
| Investing Cash Flow | - | - | - | - | - | 60 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 60 Thousand |
| Financing Cash Flow | - | - | 19.03 Thousand | - | - | 147.5 Thousand |
| Debt repayment | - | - | -145 Thousand | - | - | -147.5 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 1.49 Million | - | - | - |
| Other Financing Activities | - | - | -1.33 Million | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | 1190.00 | 1428.00 | - | 1435.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | 243.97 Thousand | 42.82 Thousand | - | 63.33 Thousand |
| Cash at beginning of period | - | - | - | - | - | - |
| Cash at end of period | - | - | - | -1428.00 | - | - |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | -1428.00 | - | - |
| Free Cash Flow | - | - | -19.03 Thousand | -1428.00 | - | -207.5 Thousand |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2022 FY | 2022 Q2 | 2022 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | -272.92 Thousand | -51.21 Thousand | - | 1.34 Million | -41.19 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 146.94 Thousand | - | - | 48.79 Thousand | -1732.00 |
| Other non-cash items | - | 126.25 Thousand | 51.21 Thousand | - | -1.13 Million | 12.7 Thousand |
| Investing Cash Flow | - | - | - | - | -248.73 Thousand | - |
| Investments in PPE | - | - | - | - | -248.73 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | -22.41 Thousand | - | - | 13.71 Thousand | 43.63 Thousand |
| Debt repayment | - | - | - | - | -3966.28 | -5400.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | -26.42 | - | - | -49.03 Thousand | 49.03 Thousand |
| Other Financing Activities | - | -22.39 Thousand | - | - | 58.78 Thousand | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | -12.7 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | -193.34 Thousand | - | - | 36.09 Thousand | 10.96 Thousand |
| Cash at beginning of period | - | 39.00 | 24.81 Thousand | - | 708.26 | 0.26 |
| Cash at end of period | - | -22.1 Thousand | 39.00 | - | 24.81 Thousand | 708.26 |
| Capital Expenditure | - | - | - | - | -248.73 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | -22.13 Thousand | -24.77 Thousand | - | 24.1 Thousand | 708.00 |
| Free Cash Flow | - | 277.93 | - | - | 10.26 Thousand | -42.92 Thousand |
009200
FAGA
JSWINFRA
0200
600717
CONCHATORO